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Abstract
Purpose Subcortical white matter is known to be relatively
unaffected by amyloid deposition in Alzheimer’s disease
(AD). We investigated the use of subcortical white matter
as a reference region to quantify [
18F]FDDNP binding in
the human brain.
Methods Dynamic [
18F]FDDNP PET studies were per-
formed on 7 control subjects and 12 AD patients. Population
efflux rate constants (k0
2) from subcortical white matter
(centrum semiovale) and cerebellar cortex were derived by a
simplified reference tissue modeling approach incorporating
physiological constraints. Regional distribution volume ratio
(DVR) estimates were derived using Logan and simplified
reference tissue approaches, with either subcortical white
matter or cerebellum as reference input. Discriminant
analysis with cross-validation was performed to classify
control subjects and AD patients.
Results The population estimates of k0
2 in subcortical white
matter did not differ significantly between control subjects
and AD patients but the variability of individual estimates
of k0
2 determined in white matter was lower than that in
cerebellum. Logan DVR showed dependence on the efflux
rate constant in white matter. The DVR estimates in the
frontal, parietal, posterior cingulate, and temporal cortices
were significantly higher in the AD group (p<0.01).
Incorporating all these regional DVR estimates as predictor
variables in discriminant analysis yielded accurate classifi-
cation of control subjects and AD patients with high
sensitivity and specificity, and the results agreed well with
those using the cerebellum as the reference region.
Conclusion Subcortical white matter can be used as a
reference region for quantitative analysis of [
18F]FDDNP
with the Logan method which allows more accurate and
less biased binding estimates, but a population efflux rate
constant has to be determined a priori.
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Positron emission tomography (PET) imaging with 2-(1-
{6-[(2-[
18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethyli-
dene)malononitrile ([
18F]FDDNP) has been found useful to
differentiate Alzheimer’s disease (AD) from mild cognitive
impairment (MCI) and normal aging [1, 2], and to show
prion protein amyloid accumulation in the brain of patients
with Gerstmann-Sträussler-Scheinker (GSS) disease [3].
[
18F]FDDNP is a hydrophobic molecular probe that crosses
the blood–brain barrier rapidly and shows excellent in vitro
fluorescence visualization of and high binding affinity for
the rigid fibrillar aggregates of width 4–20 nm, the main
components of β-amyloid plaques and neurofibrillary
tangles that are the characteristic neuropathological hall-
mark of AD [4, 5]. [
18F]FDDNP is currently the only PET
molecular imaging probe known to label both amyloid and
tangles in the living brain. The main potential for [
18F]
FDDNP is to use it to follow disease progression and
treatment response, as other tracers appear not suitable for
these purposes, i.e., they behave as on/off tracers with no
correlation with severity of disease.
A number of simplified and parametric methods have been
evaluated [6, 7] and validated against the “gold standard” of
kinetic analysis with metabolite-corrected arterial input
function [8]. Quantification of [
18F]FDDNP PET data has
been primarily based on distribution volume ratio (DVR)
using Logan graphical analysis [9], due to its robustness and
simplicity as compared to other simplified reference tissue
modeling methods with the cerebellum as reference input
[6]. The use of the cerebellum as the reference region is
based on an assumption that its amyloid deposition is
negligible. However, post-mortem studies have shown that
a diffuse type of senile plaques exists in the cerebellum of
some AD patients [10, 11]. Also, in patients with GSS, prion
protein is known to accumulate in the cerebellum [12]. The
use of the cerebellum as the reference region in these cases
and in other diseases where there is significant amyloid
deposition in the cerebellum is therefore inadequate. Thus,
there is a need to explore alternative regions which are not
affected by the pathology of the disease.
Subcortical white matter has been demonstrated to be
relatively unaffected by amyloid deposition [13], and has
been used as a reference region for [
18F]FDDNP studies in
GSS patients [3]. In this study, the use of subcortical white
matter as the reference region to quantify [
18F]FDDNP
binding in the human brain was investigated systematically.
Using the white matter as the reference region, the transport
properties of [
18F]FDDNP in control subjects and AD
patients, error analysis of the Logan method, and classifi-
cation performance in discriminating control subjects from
AD patients were evaluated, and the results were compared
to those obtained using the cerebellum as the reference
region. Differences in nonspecific binding between the
cerebellum and the subcortical white matter were also
assessed in this population. The introduction of the use of
the white matter region as a reference tissue in this work is
an important issue since it is not only specific to [
18F]
FDDNP, but is also relevant to all amyloid and neuro-
receptor imaging studies when no appropriate cortical
reference region can be used due to the presence of specific
binding.
Materials and methods
Subjects
Seven control subjects (four men, three women; age
70±9 years; MMSE score 29±1) and 12 AD patients (six
men, six women; age 74±8 years; MMSE score 18±7) were
selected from our existing subject population [1], based on
the criteria that the subjects were aged 60 years or above
and the same imaging protocol and scanner was used. All
subjects underwent thorough screening laboratory testing,
neurological and neuropsychological evaluation with Mini
Mental State Examination [14], and structural imaging
scanning to rule out other possible causes of cognitive
impairment [1]. All AD patients met the standard diagnostic
criteria of memory impairment and had progressive
impairment of memory and impairment in at least one
other cognitive domain [15]. Control subjects had normal
cognitive functioning for their age and did not meet the
criteria for MCI or AD. Written informed consent was
obtained from all subjects or from a family member or
guardian of impaired AD patients, in accordance with
procedures of the Human Subjects Protection Committee of
the University of California, Los Angeles.
[
18F]FDDNP PET imaging
Synthesis of [
18F]FDDNP has been described previously
[16]. Dynamic [
18F]FDDNP PET data were acquired on an
ECATEXACTHR+scanner (Siemens/CTI, Knoxville,TN).
Transmission scans were acquired with a set of
68Ge rotating
rod sources for 20 min to allow subsequent attenuation
correction and movement correction. Immediately after
injection of 382.2±27.6 MBq (mean±SD) of [
18F]FDDNP
through an indwelling venous catheter, dynamic PET scans
were acquired in 3-D acquisition mode for 125 min with a
scanning protocol of 6×30 s, 4×3 min, 5×10 min, and
3×20 min. Raw data were reconstructed using filtered back-
projection (Hann filter cutoff at 0.3 of the Nyquist
frequency), with correction for randoms, dead-time, scatter,
normalization, photon attenuation and decay. An image-
based head movement correction procedure was applied to
576 Eur J Nucl Med Mol Imaging (2010) 37:575–588correct for misalignments between transmission and emis-
sion scans and between emission image frames [17].
Images were analyzed with CAPP software (Siemens/
CTI, Knoxville, TN) on Sun workstations (Sun Micro-
systems, Mountain View, CA). For each subject, a
summed image of the first 6 min of emission data was
generated and regions of interest (ROIs) were then
manually drawn on the summed image for the cerebellum,
centrum semiovale (subcortical white matter), frontal,
parietal, posterior cingulate, medial temporal, and lateral
temporal regions. The summed image was used because it
reflects initial flow-dependent activity distributions that
enhance detection of distribution boundaries and cortical
regions. The ROIs were projected onto the dynamic
images at all time frames to calculate the associated
tissue time–activity curves (TACs).
Kinetic analysis
Logan graphical analysis
The equation used in the Logan graphical analysis to
determine the DVR of a reversible system using a TAC
derived from a reference region is given by [9]:
R t
0 CT t ðÞ dt
CTðtÞ
¼ DVR
R t
0 CR t ðÞ dt þ CRðtÞ
 
k0
2
CTðtÞ
þ b ð1Þ
where CR(t)a n dCT(t) denote, respectively, the activity
concentration measured by PET in the reference region and
the target region, and k0
2 (in min
−1) is a population-averaged
tissue-to-plasma efflux constant (from the reference region)
which must be assumed or determined a priori. The y-intercept,
b, includes a term which accounts for time-dependent differ-
ences between regions by using k0
2 in place of the individual
efflux rate k0
2 (in min
−1) from the reference region [9]. The
DVR can be determined as the slope of the linear portion
(t>t
*) of a plot of
R t
0 CR t ðÞ dt þ CRðtÞ
 
k0
2
    
CTðtÞ versus R t
0 CT t ðÞ dt
 
CTðtÞ. In this study, a bilinear form of Eq. 1 less
sensitive to high noise levels of CT (t) was used to determine
DVR and b:
Z t
0
CT t ðÞ dt ¼ DVR
Z t
0
CR t ðÞ dt þ CRðtÞ
 
k0
2
  
þ b   CTðtÞ
ð2Þ
When the ratio CR (t)t oCT (t) is small or reasonably constant,
the DVR can be obtained without the use of k0
2, i.e.,
R t
0 CT t ðÞ dt
CTðtÞ
¼ DVR
R t
0 CR t ðÞ dt
CTðtÞ
þ b0 ð3Þ
where b0 ¼ DVR
 
k0
2
  
CRðtÞ=CTðtÞ ðÞ þ b.
Simplified reference tissue model
Assuming that the exchange rates between the non-
displaceable and specific compartments are rapid so that
they can be combined into a single compartment and
that both reference and target regions have the same
level of nondisplaceable binding, the kinetics in the
target region can be described by a simplified reference
tissue model (SRTM) [18], using a reference region
virtually devoid of specific binding as an input function.
Defining R1 (unitless) as the ratio of delivery (or
perfusion) in the target tissue to that in the reference
region, the target tissue TAC can be fitted by a slightly
modified SRTM equation:
CTðtÞ¼R1 CRðtÞþk0
2 1  
R1
DVR
  
CRðtÞ exp  
R1k0
2
DVR
t
     
ð4Þ
where ⊗ denotes the convolution operator, and R1, k0
2 and
DVR can be estimated using the nonlinear least-squares
Levenberg-Marquardt minimization algorithm [19].
Relative perfusion from early time data
By normalizing each voxel in the summed image of the
first 6 min of dynamic image data by the sum of data
within the same time interval in the reference region,
tissue perfusion (Rp) relative to the reference region can be
estimated as:
Rp ¼
R 6min
0min CT t ðÞ dt
R 6min
0min CR t ðÞ dt
; ð5Þ
which serves as an approximation of regional delivery
relative to the reference region. Regional relative perfu-
sion can be obtained by calculating the values within the
ROIs superimposed on the Rp image. Using different
reference regions, the choice of a time interval of 0–6m i n
to generate Rp estimates has been found to be optimal
based on their variability and their goodness-of-fit against
R1 estimates obtained with SRTM for control subjects and
AD patients separately (see Results).
Data analysis
Logan graphical analysis and model fits were performed
with programs developed in-house written in C++ and
MATLAB (The MathWorks, Natick, MA). Statistical
analyses were performed using SPSS 16.0 for Windows
(SPSS, Chicago, IL). The results are presented as the
mean±1SD unless otherwise stated. A p-value <0.05 was
considered statistically significant.
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estimates
Theoretically, there should be only one value of k0
2 as there
is only one reference region. A different value of k0
2 is
estimated for different target tissues by SRTM and the
variability of k0
2 could be large. It has been suggested that a
median value of k0
2 estimated for all voxels/ROIs outside
the reference region by SRTM should be used to re-estimate
R1 and the binding potential [20]. To reduce variability and
improve parameter estimation, a modeling approach [21]
equivalent to maximum-likelihood estimation was applied
to fit all target tissue TACs simultaneously with SRTM
(SIME-SRTM) by taking advantage of the fact that k0
2 is the
same across all target regions [6]. It has been shown that
fixing k0
2 in SRTM provides significantly better results than
without fixing it [6, 7]. The median value of k0
2 estimates
obtained by SIME-SRTM for each study group was used as
the population-averaged k0
2 in the Logan analysis to
determine regional DVR values for subjects in the same
group. The standard error (SE) of the median estimate of k0
2
was calculated using median absolute deviation [22]. For
comparison, median values and SEs of k0
2 computed using
individual SRTM fits for both groups were also determined.
The use of a simpler form of Logan analysis (Eq. 3) was
also investigated.
Group comparisons
Regional Rp, R1, and DVR values were calculated as a
volume-weighted average of left and right regions. Global
values of Rp, R1, and DVR for each individual were
calculated as their corresponding mean values of posterior
cingulate, frontal, parietal, medial temporal, and lateral
temporal cortices. Correspondences between Rp and R1, and
DVR estimates obtained by the Logan method, SRTM and
SIME-SRTM were evaluated by linear regression analysis.
Group differences were examined using a nonparametric
Mann-Whitney rank-sum test. The Kruskal-Wallis test with
Dunn’s post test was used to compare differences in
regional perfusion relative to white matter obtained with
SRTM in control subjects and AD patients.
Stability of Logan DVR estimates
Logan analysis requires the definition of a time (t
*) beyond
which the linearity of the plot is assured. Identification of
this time is usually based on visual inspection. Bias and
variability of regional DVR estimates due to different
choices of t
* were assessed by progressively increasing t
*
from 15 min to 85 min. The relationship between regional
DVR estimates and total scan duration was examined by
truncating brain datasets gradually from 0–125 min to
0–65 min. The relationship between k0
2 and DVR estimates
was evaluated by varying k0
2 from −80% to +100% above
its population value. The DVR estimates obtained with
shortened total scan durations, increasing t
* and varying k0
2
were compared with the reference values obtained using the
complete 125-min datasets with t
*=35 min and k0
2 at its
population value determined by SIME-SRTM. The esti-
mates were considered stable if the result was within ±5%
of that from the reference values and the coefficient of
variation (CV) less than 10%.
Discriminant analysis
To compare the classification and prediction performance in
discriminating control subjects from AD patients using
either the subcortical white matter or the cerebellum as the
reference region, discriminant analysis [23] was conducted
on the DVR estimates of the posterior cingulate, frontal,
parietal, medial temporal, and lateral temporal cortices
(which are the regions known to be affected by amyloid
deposition) as predictor variables. The performance of
discriminant analysis was evaluated with different combi-
nations of regional DVR estimates as predictor variables
and the chi-squared (χ
2) test was used to examine the
overall accuracy in classification and prediction of group
membership using the discriminant functions [23]. To
estimate an unbiased and generalized performance measure
for correct classification of new cases, cross-validation
using a leave-one-out procedure was applied where each
case was classified by the discriminant function derived
from all cases other than that case.
Results
Clinical and cognitive measures
There were no differences between the groups in terms of
age or gender. The MMSE scores of the AD patients were
significantly lower than those of the control subjects
(p<0.001).
[
18F]FDDNP kinetics
Representative regional tissue TACs obtained from a
control subject and an AD patient are shown in Fig. 1a
and d, respectively. Slower wash-in and clearance of [
18F]
FDDNP was seen in the subcortical white matter, whereas
the wash-in and clearance in the cerebellum was much
faster and comparable with other cortical regions. The
target-to-reference ratio became relatively constant at
approximately 25 min following [
18F]FDDNP injection
when the cerebellum was used as the reference region
578 Eur J Nucl Med Mol Imaging (2010) 37:575–588(Fig. 1b and e). However, this ratio continued to decrease
and became relatively constant at only about 60 min after
injection when the white matter was used as the reference
region (Fig. 1c and f).
Perfusion relative to the reference region
The optimal time interval was investigated independently in
control subjects and AD patients using different reference
regions (i.e., subcortical white matter and cerebellum) for
calculating the relative perfusion (Rp) from the early
summed image. The time intervals used were 0–0.5, 0–1,
0–1.5, 0–2, 0–2.5, 0–3, 0–6, 0–9, and 0–12 min after
injection. Regional Rp estimates obtained with different
time intervals were compared with R1 estimates derived by
SRTM. The CV of Rp estimates was generally increased
when the interval was too short (<3 min) or too long
(>6 min), whereas time interval 0–6 min provided Rp
estimates with CV comparable to that of R1 for both study
groups and different reference regions. Linear regression
analysis showed that Rp estimates obtained with 0–6 min
were in good agreement with R1, yielding the largest r
2 and
lowest standard deviation of residuals amongst all time
intervals used, regardless of which study group and
reference region were investigated. Therefore, the optimal
time interval for calculation of Rp was determined as
0–6 min after injection, based on our scanning protocol.
Figure 2 shows the scatter plots of relative perfusion
calculated from the summed image data (Rp) within the first
6 min after injection of [
18F]FDDNP and from the SRTM
(R1) in various regions, using white matter and cerebellum
as reference regions. The Rp estimates of perfusion relative
to white matter and cerebellum were about 20% and 13%
lower than the R1 estimates obtained by SRTM. However,
there was a strong correlation (r>0.97) between Rp and R1
estimates in both the control and AD groups. Regional and
global R1 estimates obtained with SRTM using the white
matter as the reference region are summarized in Table 1.
No significant differences were observed in regional and
global R1 values between control subjects and AD patients
but the difference among regions was statistically signifi-
cant (Kruskal-Wallis test, p<0.0001). Dunn’s post test
revealed that there were significant differences in the
medial temporal region (in both groups) as compared to
the posterior cingulate in both groups (p<0.01) and to the
frontal region in AD patients (p<0.05). Similar results were
obtained for SIME-SRTM (data not shown).
Determination of population efflux rate constant
Variability of median estimate (in terms of CV) of k0
2
derived by SRTM was 20±7% in white matter and 73±20%
in cerebellum for control subjects, and 24±8% in white
matter and 46±14% in cerebellum for AD patients.
Improved estimates were obtained for k0
2 by SIME-SRTM
as the variability was reduced tremendously in both control
subjects (2.1±0.4% for white matter and 6.7±1.1% for
cerebellum) and AD patients (2.2±0.4% for white matter
Fig. 1 Representative tissue TACs of a control subject (a) and an AD patient (d), and their ratios to the cerebellum (b, e) and white matter (c, f)
(FRT frontal, PAR parietal, MTL medial temporal, LTL lateral temporal, PCG posterior cingulate, CBL cerebellum, SWM subcortical white matter)
Eur J Nucl Med Mol Imaging (2010) 37:575–588 579and 5.8±1.4% for cerebellum). The population estimates
(median±SE) of k0
2 (i.e., k0
2) in white matter derived by SIME-
SRTM were 0.023±0.005 min
−1 and 0.023±0.004 min
−1 for
control subjects and AD patients, respectively, and did not
differ significantly. Variability of k0
2 determined by SIME-
SRTM in white matter was similar to that in cerebellum, whose
estimates (median±SE) of k0
2 were 0.091±0.014 min
−1 and
0.086±0.021 min
−1 for control subjects and AD patients,
respectively. These estimates were not significantly different
from those obtained by SRTM.
Nonspecific binding
Figure 3 shows the Logan plots on the frontal cortex for a
control subject without specific binding and in a typical AD
patient using, respectively, the cerebellum and the subcortical
white matter as reference region. The DVR values obtained
with either reference region were identical for the control
subject and were only slightly lower for the AD patient when
the subcortical white matter was used as the reference region.
To further demonstrate the similarity in nonspecific binding
between the cerebellum and the subcortical white matter,
Logan analysis was performed using, respectively, the
subcortical white matter and the cerebellum as reference
region. Representative results are shown in Fig. 4 for the
same subjects shown in Fig. 3.T h eD V Rv a l u e so b t a i n e df o r
subcortical white matter and the cerebellum using their
counterpart as reference region were very close to unity
(1.02±0.04 and 0.98±0.05 for control subjects; 1.04±0.03
and 0.96±0.03 for AD patients), indicating that the levels of
nonspecific binding in these regions were very similar.
Logan DVR with reference tissue input
Parametric DVR images using the white matter as the
reference region for a control subject and an AD patient are
shown in Fig. 5. The images were generated by applying
Logan analysis on a voxel-by-voxel basis to dynamic PET
images using data from 0–125 min (t
*=35 min). Binding of
[
18F]FDDNP in the medial temporal, lateral temporal,
posterior cingulate, parietal, and frontal regions was much
more prominent in the AD patient than in the control
subject. Regional DVR values obtained by Logan analysis
using different reference regions are shown in Fig. 6. The
regional and global DVR values were significantly higher
in AD patients in comparison with control subjects. In both
study groups, the rank order for DVR estimates was: medial
temporal region > posterior cingulate > lateral temporal
region > parietal region > frontal region. The same rank
order was also observed for DVR estimates obtained with
Fig. 2 Correlations between estimates of relative perfusion (to the
reference region) using the summed image data (Rp) within the first
6 min after injection of [
18F]FDDNP, and perfusion (relative to the
reference region) obtained by SRTM (R1) for various regions in
control subjects and AD patients. The reference regions were white
matter (a) and cerebellum (b). Regression lines are shown in gray
(FRT frontal, PAR parietal, MTL medial temporal, LTL lateral
temporal, PCG posterior cingulate)
Table 1 Regional R1 obtained with SRTM using subcortical white matter as reference region. Values are mean±SD
Group
a Frontal Parietal Medial temporal Lateral temporal Posterior cingulate Global
Control 2.42±0.32 2.61±0.33 1.86±0.22 2.32±0.34 2.97±0.42 2.44±0.31
AD 2.62±0.49 2.51±0.51 1.97±0.30 2.33±0.46 2.84±0.57 2.45±0.45
p<0.05, Medial temporal/Control vs Frontal/AD, and Medial temporal/AD vs Frontal/AD; p<0.01, Medial temporal vs Posterior cingulate, in both
the control and AD groups; Dunn’s post test.
aNo significant difference was observed between the control and AD groups, but there were significant differences across regions (Kruskal-Wallis
test, p<0.0001).
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values obtained using either reference region were related
by DVR[white matter as reference region]=0.96 DVR[cerebellum as
reference region] (r=0.81, p<0.0001). This linear relation can be
derived from the ratio of the specific binding to the
nondisplaceable binding using different reference regions
(see Appendix).
The DVR estimates obtained with either SRTM or
SIME-SRTM using white matter as reference region were
in good agreement with those derived by the Logan method
(DVR[SRTM]=0.97 DVR[Logan] + 0.02, r=0.96, p<0.0001;
DVR[SIME-SRTM]=1.04 DVR[Logan] − 0.06, r=0.95,
p<0.0001). Neither the slopes nor the intercepts of the
regression lines differed significantly from one or zero,
respectively (extra sum-of-squares F-test, p>0.05).
Time stability of Logan DVR
Figure 7 shows the effect of t
* on the accuracy of Logan
DVR in control subjects and AD patients with complete
datasets (0–125 min). The bias in DVR values due to
increasing t
* from 15 min to 85 min was calculated using
estimates obtained with t
*=35 min as reference and was
slightly larger in control subjects than in AD patients. The
variability of regional DVRs obtained with t
* between
15 min and 65 min was similar to those obtained with
t
*=35 min, but increased appreciably when t
*>65 min,
especially in the posterior cingulate. The maximum
allowable t
* was found to be 45 min without introducing
significant bias and variability to the DVR estimates.
Figure 8 shows the effect of total scan duration on the
accuracy of regional DVR estimates derived by Logan
analysis in control subjects and AD patients with
t
*=35 min. When the total scan duration was shortened
from 125 min to 65 min, the DVR estimates and the
variability in all regions steadily decreased and increased,
respectively. However, less than 5% changes were observed
for regional DVR estimates and the CV was less than 10%
even though the total scan duration was shortened to
65 min.
Fig. 3 Logan DVR plots on the frontal cortex for a control subject (a)
and an AD patient (b) using the cerebellum (CBL) and the subcortical
white matter (SWM) as reference region, respectively. The value of k0
2
was 0.023 min
−1 when SWM was used as the reference region and it
was 0.091 min
−1 for the control subject and 0.086 min
−1 for the AD
patient when CBL was used as the reference region. Note the
similarity in DVR values derived using either reference region. The
time point corresponding to the “pseudo” equilibrium (t
*=25 min) is
also shown
Fig. 4 Logan DVR plot on the
cerebellum using the subcortical
white matter as reference region
(a) and the subcortical white
matter using the cerebellum as
reference region (b) for the same
subjects as shown in Fig. 3. The
time point corresponding to the
“pseudo” equilibrium
(t
*=25 min) is also shown
Eur J Nucl Med Mol Imaging (2010) 37:575–588 581Fig. 5 Representative parametric images of Logan DVR using 125 min of data (with t
*=35 min) and white matter as reference input in a control
subject (a) and an AD patient (b)
Fig. 6 Scatter plots of regional
[
18F]FDDNP binding derived by
the Logan method using white
matter (a) and cerebellum (b)a s
reference regions. Long and
short horizontal bars represent
means and standard deviations,
respectively. The p-values were
calculated using a nonparametric
Mann-Whitney rank-sum test
(one-tailed)
582 Eur J Nucl Med Mol Imaging (2010) 37:575–588Fig. 7 Effect of varying t
* on
the stability of regional DVR
values derived by the Logan
method with subcortical white
matter as reference region in
control subjects and AD patients
for each region (n=5) and each
subject (n=7 control subjects,
n=12 AD patients). Percentage
differences in DVR values due
to increasing t
* from 15 min to
85 min were calculated using
estimates obtained with
t
*=35 min as reference values
and are shown for control sub-
jects (a) and AD patients (c),
and the corresponding variabili-
ty is shown for control subjects
(b) and AD patients (d)
Fig. 8 Effect of total scan dura-
tion on the stability of regional
DVR values derived by the
Logan method with subcortical
white matter as reference region
in control subjects and AD
patients for each region (n=5)
and each subject (n=7 control
subjects, n=12 AD patients).
Regional DVR values derived
with shorter datasets, expressed
as a percentage difference from
their reference values estimated
with the complete datasets
(125 min of data collection and
t
*=35 min) are shown for con-
trol subjects (a) and AD patients
(c). The variability, expressed as
%CV, is shown for control sub-
jects (b) and AD patients (d)
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Figure 9 shows the effect of the value of k0
2 on the accuracy
of DVRs derived by Logan analysis. All regions exhibited a
similarly large dependence on the value of k0
2 in both
control subjects and AD patients. Varying the value of k0
2
from −80% to +100% above the population value of
0.023 min
−1 resulted in variations in the regional DVR
values varied from −19.7% to +3.1% in control subjects
(Fig. 9a) and from −21.2% to +3.4% in AD patients
(Fig. 9b) over their means and the DVR values were more
susceptible to negative bias in the k0
2 value. Increasing k0
2
tenfold (which covered a wide range of plausible values) or
eliminating the term k0
2 from the calculation of DVR
resulted in a variation ranging from +1.5% to +7.1% in
all regions examined.
Discriminant analysis
Table 2 summarizes the classification accuracy, sensitivity
and specificity of discriminant analysis using different
combinations of regional DVR estimates as predictor
variables. The classification performance was generally
improved when more predictor variables were included in
the discriminant analysis. There was an excellent discrim-
ination between control subjects and AD patients, with
100% classification accuracy using either the white matter
(#2
ð5Þ ¼ 27:3, p<0.001) or the cerebellum (#2
ð5Þ ¼ 22:4,
p<0.001) as the reference region when the discriminant
analysis conducted on the Logan DVR estimates of the
posterior cingulate, and frontal, parietal, medial temporal,
and lateral temporal regions with complete datasets
(0–125 min). The leave-one-out cross-validation procedure
yielded 92% sensitivity and 100% specificity, with an
overall accuracy of 95% for using either reference region.
Discussion
The primary aims of this study were to evaluate the use of
the subcortical white matter as a reference region and to
determine whether it is a good alternative to the cerebellum,
which could be affected by disease. It is an important issue
that is not only specific to [
18F]FDDNP for amyloid
imaging but also relevant to generic neuroreceptor studies
when no appropriate cortical region can be used as
reference tissue due to the presence of specific binding.
Post-mortem studies have shown that amyloid deposition in
the white matter is much less than in most cortical regions
and the cerebellum. The most important finding in this
study is that regional DVRs obtained with the white matter
as the reference region possess the same distinguishing
ability as those obtained with the cerebellum, and show
significant differences between control subjects and AD
patients. The regional binding of [
18F]FDDNP agrees well
with topographical patterns of pathological distribution
seen at autopsy [13, 24, 25]. In this regard, the subcortical
white matter may be an adequate alternative reference
region to the cerebellum when the latter is affected by the
pathology of the disease. A typical example is in prion
disease such as GSS syndrome whose pathological hall-
mark is the presence of numerous mutant prion protein
amyloid deposits throughout the cerebral cortices, especial-
ly in the cerebellum [12], where [
18F]FDDNP binding has
been found to be elevated [3].
Recent studies [6, 7] have demonstrated that the full
reference tissue model [26] provides less reliable fits to
regional [
18F]FDDNP kinetics than SRTM. Therefore, only
SRTM was considered in this study and the results were
compared with those from the Logan method. While SRTM
provides more kinetics information such as transport, efflux
and binding, it has more stringent requirements than Logan
analysis that need to be satisfied. In addition to assuming
that the reference region contains no or negligible specific
binding, the kinetics in both target and reference regions
need to be adequately described by a one-tissue compart-
ment model [18]. If this latter assumption is violated,
Fig. 9 Effect of variation in k0
2 in white matter on the accuracy of
DVRs derived by Logan graphical analysis in control subjects (a) and
AD patients (b). Variations in DVR in the frontal region (FRT),
parietal region (PAR), medial temporal region (MTL), lateral temporal
region (LTL), and posterior cingulate (PCG) were determined using an
assumed k0
2 value of 0.023 min
−1
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reference region, the DVR estimates obtained by SRTM
will be biased [20]. This assumption was checked using the
same model evaluation strategies adopted by Wong et al.
[6], and it was found that SRTM outperformed the full
reference tissue model in 85% of model fits using the white
matter as the reference region (data not shown). This
finding is in line with the findings of our previous study [6]
and that by Yaqub et al. [8] who concluded that, although it
might not be ideal, SRTM is the method of choice for
quantitative analysis of [
18F]FDDNP data. On the contrary,
although Logan analysis might not be ideal, the good
correspondence with SRTM as indicated by our results and
those of Yaqub et al. [7], and the robustness and
computational ease of Logan analysis would make this
approach practical and attractive for routine parametric
mapping of amyloid and tau deposition with [
18F]FDDNP
PET.
Due to different composition of gray matter and white
matter, it is likely that the nonspecific binding in these
regions would not be the same. However, their ratio should
be quite constant. Our data showed that the nonspecific
binding of [
18F]FDDNP in these regions was quite similar
and was close to 1 (Figs. 3 and 4). The slight difference in
nonspecific binding between the cerebellum and the
subcortical white matter caused a slight but constant DVR
bias (lowered by about 5%) in all gray matter target regions
over subjects and groups when using the white matter
rather than the cerebellum as reference region. However,
this may not be true for other amyloid imaging probes such
as [
11C]PIB and [
18F]BAY94-9172 as indicated by the large
DVR values in the subcortical white matter with cerebellum
as reference region (control subjects 1.33±0.06, AD patients
1.34±0.18 for [
11C]PIB [27]; control subjects 1.93±0.18, AD
patients 1.89±0.45 for [
18F]BAY94-9172 [28]), and thus
these probes will need to be carefully investigated. The same
is also true, and perhaps even more important, for neuro-
receptor studies, as in that case it is more likely that
nonspecific binding could be different between gray matter
and white matter.
The hydrophobic nature of [
18F]FDDNP makes it highly
permeable through the blood–brain barrier. Delivery of the
tracer from blood to tissue is mostly perfusion-limited and
the vascular volume, for all practical purposes, can be
considered as part of the tissue compartment of free [
18F]
FDDNP. Therefore, the effect of blood volume on the
estimate of relative perfusion or K1 is expected to be
relatively small. The initial image data obtained immedi-
ately after injection of [
18F]FDDNP thus mainly reflects
perfusion-dependent activity distributions. Relative perfu-
sion (to the reference region) could be obtained by
normalizing regional perfusion with that in the reference
region. Perfusion estimates obtained by this approach (Rp)
were slightly lower than but highly correlated with those
(R1) derived by SRTM (Fig. 2).
While the forward transport of [
18F]FDDNP is flow-
dependent and the difference in perfusion between gray
matter and white matter is much larger than it is between
gray matter regions where reference tissue models are
usually applied, a slowly perfused (reference) region would
simply indicate that a longer time is required for tracer
delivery and for reaching a “steady-state” equilibrium, and
thus a longer t
* is needed to derive Logan DVR. This is
problematic for compounds with short half-lives but not so
Table 2 Classification accuracy, sensitivity, and specificity (%) using regional Logan DVR values derived with subcortical white matter and
cerebellum as reference input
Regions Reference region
Subcortical white matter Cerebellum
Accuracy Sensitivity Specificity Accuracy Sensitivity Specificity
FRT+PAR+MTL+LTL+PCG 100 (95) 100 (92) 100 (100) 100 (95) 100 (92) 100 (100)
FRT+MTL+LTL+PCG 100 (95) 100 (92) 100 (100) 100 (95) 100 (92) 100 (100)
PAR+FRT+MTL+PCG 100 (95) 100 (92) 100 (100) 100 (95) 100 (92) 100 (100)
FRT+MTL+LTL 100 (95) 100 (92) 100 (100) 100 (95) 100 (92) 100 (100)
FRT+MTL+PCG 100 (95) 100 (92) 100 (100) 100 (95) 100 (92) 100 (100)
MTL+LTL+PCG 90 (90) 92 (92) 86 (86) 95 (90) 100 (92) 86 (86)
PCG+PAR 95 (90) 92 (83) 100 (100) 90 (90) 92 (92) 86 (86)
PCG+LTL 95 (90) 100 (92) 86 (86) 90 (90) 92 (92) 86 (86)
PAR+LTL 90 (90) 92 (92) 86 (86) 90 (84) 92 (92) 86 (71)
Cross-validated values are given in parentheses.
FRT frontal, PAR parietal, MTL medial temporal, LTL lateral temporal, PCG posterior cingulate.
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18F-labeled compounds, which typically have a longer
data acquisition time. Since DVR represents equilibrium
binding quantity and as such is independent of blood flow
[9, 29]. Our data suggest that a “pseudo” equilibrium
condition is typically reached by 25 min after injection
(Figs. 3 and 4) even though “steady-state” equilibrium is
not yet attained and the calculated DVR values were quite
stable (Figs. 7 and 8). Therefore, providing that the blood
flow is reasonably stable during the period of study,
differences in blood flow between gray matter and white
matter do not limit the use of white matter as a reference
region. Consequently, elevated regional DVR seen in
AD patients as compared to control subjects should not
be due to decreased perfusion. This argument was
supported by the observations that there was no
significant difference in regional relative delivery be-
tween control subjects and AD patients (Table 1)a n d
that the rank order of DVR values (Fig. 6) was consistent
with the typical rank order of amyloid deposits found in
post-mortem AD brains [13, 24, 25].
The use of the reference tissue approach requires that R1
is relatively constant across different brain regions [30].
Our results showed that this requirement was well satisfied,
as R1 values were very similar across regions, except in the
medial temporal region, where lower R1 values were
observed in both groups (Table 1), likely due to various
confounding factors, including partial volume effect and the
reconstruction algorithm used. The relatively small size of
the medial temporal region also makes it prone to higher
anatomic variability with aging and degeneration. It is
worth mentioning that metabolic and perfusion studies have
yielded conflicting results on the functional status of the
medial temporal region in patients with AD [31, 32].
Although the efflux rate constant for a given population
needs to be determined a priori, this work and also a recent
study [7] indicate that regional [
18F]FDDNP binding is
relatively insensitive to the value of the efflux rate constant
chosen, and the efflux rate constants for normal control
subjects and AD patients are similar for a given reference
region. We expect that efflux rate constants for subjects
with MCI or frontotemporal dementia would be similar to
those of normal control subjects and AD patients.
ThedecreasingratiooftargetROItowhitemattershownin
Fig. 1 suggests that the determination of the Logan DVR is
sensitive to the CRðtÞ
 
k0
2 term in Eqs. 1 and 2. Even though
CTðtÞ=CRðtÞ was relatively constant after 40 min, larger bias
and variance were seen in DVR estimates derived with Eq. 3,
particularly when the total scan duration was shortened (data
not shown). Therefore, the use of the simpler form of Logan
analysis is not recommended when white matter is used as
the reference region. The dependence of the DVR estimates
on the value of k0
2 is shown in Fig. 9 for the frontal, parietal,
medial temporal, lateral temporal and posterior cingulate
regions. All regions exhibited a large dependence on the
value of k0
2 in both control subject and AD groups and were
more susceptible to negative bias on k0
2.
While there were significant differences in regional DVR
between control subjects and AD patients, the degree of
overlap between the groups was such that using a single
DVR parameter in any region lacked sensitivity. Discrim-
inant analysis provides an objective means to classify
subjects by using multiple regional DVR parameters as
predictor variables in conjunction with known group
information. Considering DVR parameters of multiple
regions simultaneously in discriminant analysis yielded
highly accurate classification of control subjects and AD
patients, and the results using the white matter or the
cerebellum as the reference region were in very good
agreement (Table 2). By using DVR parameters in five
regions (frontal, parietal, medial temporal, lateral temporal,
and posterior cingulate), excellent discrimination between
control subjects and AD patients was achieved, with 100%
sensitivity, specificity and classification accuracy (cross-
validated 95%), using either reference regions (Table 2).
There is a concern that retrospective selection of subjects
is not the appropriate approach when the intent is
discriminating AD patients from control subjects, espe-
cially when a predictive model is to be developed.
However, it should be noted that the “diagnostic perfor-
mance” r e s u l t sr e p o r t e di nT a b l e2 a r en o tr e l a t e dt ot h e
retrospective selection of subjects. Instead, Table 2 was
intended only to show comparisons of classification
performance based on regional DVR parameters derived
with different reference regions (i.e., subcortical white
matter versus cerebellum) regardless of clinical diagnosis.
It was demonstrated that both reference regions provided
virtually identical results for overall accuracy, sensitivity,
and specificity of classification.
In practice, it is not known in advance whether the
cerebellum would be affected by disease if blood data are
not available. However, due to its invasiveness, peripheral
bloodsamplingisnotpracticalinaclinicalsettingbecauseitis
laborious and may not be tolerated by the patient particularly
when longitudinal evaluations are required. Despite the slight
systematically lower DVR values obtained with subcortical
white matter, it performed as well as the cerebellum as
reference region in terms of overall subject classification
accuracy and regional DVR comparisons between subject
groups. Therefore, when blood data are not available or blood
sampling is not feasible due to practical clinical consider-
ations, both subcortical white matter and the cerebellum
should be used together as a quality check to assess if there is
any discrepancy in the results that may require further
investigation along with other clinical information. On the
other hand, the control subjects and AD patients included in
this study were not patients with specific vascular abnormal-
586 Eur J Nucl Med Mol Imaging (2010) 37:575–588ities, vascular dementia, or multiple sclerosis. For subjects
withthesediseases,theuseofwhitematterasreferenceregion
would require further validation and careful investigation.
Indeed, this is one of the subjects of our future research.
Conclusion
We evaluated the use of the subcortical white matter as the
reference region for quantitative analysis of [
18F]FDDNP
PET data and the results were compared with those using
the cerebellum as the reference region. The use of the white
matter as a reference region is possible with [
18F]FDDNP
PET determinations because the steady-state ratio of white
matter over cerebellum is constant and close to 1 (control
subjects 1.02±0.04; AD patients 1.04±0.03). Our results
suggest that Logan graphical analysis is a robust method to
derive regional DVR parameters with low bias and
variability and is independent of tracer delivery, but it
shows dependence on the efflux rate constant in subcortical
white matter that needs to be determined a priori (e.g., by
model fitting with a physiological constraint). The rank
order of DVR values derived using the white matter as the
reference region agrees well with that using the cerebellum
as the reference region and is consistent with the typical
rank order of amyloid deposits seen at autopsy. The
performance in classifying subjects by discriminant
analysis using the subcortical white matter as the
reference region was similar to that using the cerebellum
as the reference region. Therefore, the subcortical white
matter is a good alternative reference region to the
cerebellum for analyzing [
18F]FDDNP PET data particu-
larly when the latter region is affected by disease. In
practice, both the subcortical white matter and the
cerebellum should be used together to cross-validate the
findings with different reference regions, especially when
blood data are not available or blood sampling is not
feasible due to practical clinical considerations.
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Appendix
Theoretically, the relation between the regional DVR values
obtained using either reference region can be derived from
the ratio of the specific binding (VT−VND) to the non-
displaceable binding (VND), i.e.,
BPND  
VT   VND
VND
¼
VT
VND
  1 ðA1Þ
where VT and VND represent the total distribution volume
(DV) and nondisplaceable DV, respectively [33]. The latter
parameter can be measured as VT in a reference region.
Denote VND(CBL) and VND(SWM) as the nondisplaceable (or
total) DVs of the cerebellum (CBL) and the subcortical
white matter (SWM), respectively. It is likely that VND(CBL)
and VND(SWM) would not be the same but their ratio should be
constant andis related by VND(CBL)/VND(SWM) = c,w h e r ec is a
constant. For a target region with VT as the total DV, if the
cerebellum is used as the reference region, then from Eq. A1:
BPNDðCBLÞ ¼
VT
VND CBL ðÞ
  1  
VT
c   VND SWM ðÞ
  1 ðA2Þ
Similarly, if the subcortical white matter is used as reference
region, then
BPNDðSWMÞ ¼
VT
VND SWM ðÞ
  1 ðA3Þ
Denote DVRCBL   VT
 
VND CBL ðÞ ¼ BPNDðCBLÞ þ 1a n d
DVRSWM   VT
 
VND SWM ðÞ ¼ BPNDðSWMÞ þ 1 as the DVR
values obtained using thecerebellum and thesubcorticalwhite
matter as reference region, respectively. Substituting DVRCBL,
DVRSWM and Eq. A3 into Eq. A2 and rearranging, we have:
DVRCBL ¼ c0   DVRSWM ðA4Þ
or
DVRSWM ¼ c   DVRCBL ðA5Þ
where c0 ¼ 1=c. Therefore, regional DVR values obtained
with the subcortical white matter and the cerebellum can be
compared and related by a constant, and their relationship can
Eur J Nucl Med Mol Imaging (2010) 37:575–588 587be determined by additional measurements (e.g., from
blocking and displacement studies) or by linear regression
on the DVR values derived using either reference region.
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